Lucero awarded €1.3M Transition grant by European Innovation Council
Gothenburg, Nov. 14, 2022 – Lucero AB has received the European Innovation Council’s (EIC) Transition grant to continue developing its 3D cell culture handling platform.
Gothenburg, Nov. 14, 2022 – Lucero AB has received the European Innovation Council’s (EIC) Transition grant to continue developing its 3D cell culture handling platform.
Viable hepatocyte (HepG2) spheroids were created using the hanging-drop method by Lucero’s Tinde Höjer.
Lucero awarded 900 000 SEK Vinnova Innovative Startups Stage 2 grant to build on Stage 1 progress in preparation for an on-site pharmaceutical pilot project and Seed round funding.
Preliminary data showed a temperature increase of less than 1 degree C in HepG2 cells during exposure to optical tweezers.
Lucero has been granted a project by the European initiative, MedPhab, to accelerate the development of its novel microfluidic well plates with the help of partners, Joanneum Research and The Technical Research Center of Finland (VTT).